Mind over fatigue: new study tests meditation and yoga for blood cancer patients
NCT ID NCT03735992
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a mind-body group program can help reduce fatigue in people who have finished treatment for blood cancers like leukemia or lymphoma. The program includes relaxation, gentle exercise, and stress management techniques. Researchers will compare fatigue levels between those who take the program and those who don't, with 94 participants total.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
mind-body group program (based on MBSR and mind-body medicine)
What this could lead to
If it works, this could offer a drug-free way to manage fatigue and improve quality of life for blood cancer survivors.
What could go wrong
This is a small, early-stage trial with no blinding, so results may be influenced by placebo effects. The program requires significant time commitment and may not work for everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Robert-Bosch-Krankenhaus, Abteilung für Hämatologie, Onkologie und Palliativmedizin
RECRUITINGStuttgart, 70376, Germany
Contact Email: •••••@•••••
Contact Email: •••••@•••••